BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12500295)

  • 1. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.
    Macey M; McCarthy D; Azam U; Milne T; Golledge P; Newland A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):30-40. PubMed ID: 12500295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy.
    Ahnadi CE; Sabrinah Chapman E; Lépine M; Okrongly D; Pujol-Moix N; Hernández A; Boughrassa F; Grant AM
    Thromb Haemost; 2003 Nov; 90(5):940-8. PubMed ID: 14597991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system.
    Macey M; Azam U; McCarthy D; Webb L; Chapman ES; Okrongly D; Zelmanovic D; Newland A
    Clin Chem; 2002 Jun; 48(6 Pt 1):891-9. PubMed ID: 12029005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.
    Macey M; Hagi-Pavli E; Stewart J; Wallace GR; Stanford M; Shirlaw P; Fortune F
    Rheumatology (Oxford); 2011 Oct; 50(10):1849-59. PubMed ID: 21719422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of anticoagulants and storage temperature on immature platelet fraction % (IPF%) values in stored samples measured by the automated hematology analyzer, XE-5000--utility of CTAD-anticoagulation and room temperature storage].
    Nishiyama M; Hayashi S; Kabutomori O; Yamanishi H; Suehisa E; Kurata Y; Kashiwagi H; Tomiyama Y
    Rinsho Byori; 2011 May; 59(5):452-8. PubMed ID: 21706858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of platelet activation in platelet concentrates measured by flow cytometry or ADVIA 2120.
    Beard MJ; Jeewa Z; Bashir S; Cardigan R; Thomas S
    Vox Sang; 2011 Aug; 101(2):122-30. PubMed ID: 21492182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of platelet clumping and complete blood count results with Sysmex XT-2000iV in feline blood sampled on EDTA or EDTA plus CTAD (citrate, theophylline, adenosine and dipyridamole).
    Granat F; Geffré A; Braun JP; Trumel C
    J Feline Med Surg; 2011 Dec; 13(12):953-8. PubMed ID: 22079363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole.
    Kühne T; Hornstein A; Semple J; Chang W; Blanchette V; Freedman J
    Am J Hematol; 1995 Sep; 50(1):40-5. PubMed ID: 7668222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant.
    Mody M; Lazarus AH; Semple JW; Freedman J
    Transfus Med; 1999 Jun; 9(2):147-54. PubMed ID: 10354385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis.
    Schrezenmeier H; Müller H; Gunsilius E; Heimpel H; Seifried E
    Thromb Haemost; 1995 Mar; 73(3):506-13. PubMed ID: 7545322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilization of the mean platelet volume and component measured with the ADVIA counters.
    Diaz-Ricart M; Brunso L; Pino M; Navalon F; Jou JM; Heras M; White JG; Escolar G
    Thromb Res; 2010 Jul; 126(1):e30-5. PubMed ID: 20427079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in haematology measurements with the Sysmex XT-2000iV during storage of feline blood sampled in EDTA or EDTA plus CTAD.
    Granat F; Geffré A; Bourgès-Abella N; Braun JP; Trumel C
    J Feline Med Surg; 2013 Jun; 15(6):433-44. PubMed ID: 23264612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system.
    Macey MG; Carty E; Webb L; Chapman ES; Zelmanovic D; Okrongly D; Rampton DS; Newland AC
    Cytometry; 1999 Oct; 38(5):250-5. PubMed ID: 10516612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole blood microvolume laser scanning cytometry for monitoring resting and activated platelets.
    Wyant TL; Smith PC; Brown B; Kantor AB
    Platelets; 2001 Aug; 12(5):309-18. PubMed ID: 11487384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instrumental reports and effect of anticoagulants in a case of neutrophil agglutination in vitro.
    Galifi M; Schinella M; Nicoli M; Lippi G
    Haematologica; 1993; 78(6):364-70. PubMed ID: 7503816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil and platelet activation in equine recurrent airway obstruction is associated with increased neutrophil CD13 expression, but not platelet CD41/61 and CD62P or neutrophil-platelet aggregate formation.
    Dunkel B; Rickards KJ; Werling D; Page CP; Cunningham FM
    Vet Immunol Immunopathol; 2009 Sep; 131(1-2):25-32. PubMed ID: 19362377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved circulating microparticle analysis in acid-citrate dextrose (ACD) anticoagulant tube.
    György B; Pálóczi K; Kovács A; Barabás E; Bekő G; Várnai K; Pállinger É; Szabó-Taylor K; Szabó TG; Kiss AA; Falus A; Buzás EI
    Thromb Res; 2014 Feb; 133(2):285-92. PubMed ID: 24360116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
    Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
    Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
    Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
    Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood.
    Lu Q; Malinauskas RA
    Artif Organs; 2011 Feb; 35(2):137-44. PubMed ID: 20946295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.